热门资讯> 正文

Pelthos Therapeutics任命John M.同性恋担任首席财务官

2026-04-11 05:11

Pelthos Therapeutics (PTHS) announced on Friday the appointment of John M. Gay as CFO, effective April 10, 2026, succeeding Francis Knuettel II.
Gay brings over 25 years of public company finance and accounting experience, having served as the company's SVP, Finance & Accounting since 2025.
He previously served as CFO of LNHC and in senior roles at Furiex Pharmaceuticals.

More on Pelthos Therapeutics

Pelthos Therapeutics Inc. (PTHS) Q4 2025 Earnings Call Transcript
Pelthos signals continued ZELSUVMI momentum and targets expanded product launches through 2027
Quant snapshot: Micron, Babcock & Wilcox lead strong buys as Fold Holdings, Alvotech lag
Seeking Alpha’s Quant Rating on Pelthos Therapeutics
Historical earnings data for Pelthos Therapeutics

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。